Exclusive: Inside the fall of Vinay Prasad at the FDA

Prasad's departure followed a campaign by a right-wing activist and a controversy over a rare disease drug.

July 30, 2025 Check out STAT+

Sponsored By

Photo illustration Alex Hogan/STAT STAT+ | Inside the fall of Vinay Prasad at the FDA Prasad's departure follows criticism from MAGA and MAHA, a campaign by a right-wing activist, and a controversy over a rare disease drug. By Lizzy Lawrence STAT+ | Top White House pandemic preparedness official resigns, officials say, in sign of broader disarray Gerald Parker's exit leaves White House's pandemic preparedness team leaderless. Expert warnings of danger called "fake news" by Trump administration. By Katherine Eban STAT+ | Trump administration reverses course, lifts pause on NIH grant awards The Office of Management and Budget ordered NIH to halt issuing research grants and contracts during a "pause" of unspecified duration  By Angus Chen, Megan Molteni, and Anil Oza Molly Ferguson for STAT STAT+ | Vinay Prasad was not good for the FDA. But his ouster makes things worse Prasad's weakness left him exposed to politics, but his removal may weaken the agency's ability to adhere to good science. By Matthew Herper STAT+ | Health care and tech companies promise CMS they'll make patient data more accessible Over 60 organizations signed on to a pledge orchestrated by the Centers for Medicare and Medicaid Services to make health data-sharing easier. By Mario Aguilar and Brittany Trang Trump nominee for top HHS post pushed to ban methadone treatment As a West Virginia state senator, Mike Stuart sponsored or co-sponsored legislation to ban opioid treatment programs and needle exchanges. By Lev Facher Adobe STAT breaks down the confusing, heartbreaking Sarepta saga Sarepta Therapeutics is in the news because of its gene therapy for Duchenne muscular dystrophy. STATus Report host Alex Hogan goes behind the headlines. By Alex Hogan STAT+ | FDA names drug regulator Tidmarsh acting head of biologics center after Prasad's exit George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad. By Lizzy Lawrence STAT+ | Using mRNA, scientists overcome a key challenge to HIV vaccines Scientists test a messenger RNA-based vaccine to circumvent a longstanding challenge in designing protection against rapidly mutating virus By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser